The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.
Level 5 - mechanism / opinion, no new human data
Preclinical in vitro and animal model (EAE mice) study.
PubMed 17339406 · doi:10.1084/jem.20061931
What was done
Mechanistic and animal intervention study investigating the role of fibrinogen in microglia activation and central nervous system autoimmune demyelination. Investigators assessed signaling through the microglia integrin receptor Mac-1 (CD11b/CD18) involving Akt and Rho pathways, and evaluated the effect of disrupting this interaction in mice with experimental autoimmune encephalomyelitis (EAE) using either genetic modification (fibrinogen-gamma390-396A knock-in mice) or intranasal delivery of the inhibitory peptide gamma(377-395).
What was found
The abstract reports qualitative outcomes without specific numerical values, sample sizes, or statistical confidence intervals. Fibrinogen stimulated microglia differentiation into phagocytes through Mac-1 via Akt and Rho signaling. Both genetic disruption and pharmacologic blockade with the intranasal gamma(377-395) peptide attenuated microglia activation and suppressed relapsing paralysis in EAE mice while maintaining normal coagulation properties.
Why it matters
It identifies a specific molecular target (the gamma377-395 epitope of fibrinogen) that uncouples fibrinogen's proinflammatory neurodegenerative effects from its essential blood clotting functions, highlighting a potential therapeutic strategy for multiple sclerosis.
Limits
All findings are derived from rodent models and in vitro systems, limiting direct translatability to human multiple sclerosis. The abstract provides no quantitative data, effect magnitudes, treatment timelines, or animal cohort sizes. Long-term safety, pharmacokinetics, and potential off-target effects of the intranasal peptide were not described in the abstract.
Cited by
- supports Fibrinogen binds to CD11b receptors on microglia, triggering an inflammatory reaction in the brain.